Strategies helps businesses and individuals solve the complexities of dealing with the government at every level. Our team of specialists concentrate exclusively on government affairs, representing clients nationwide who need assistance with public policy, advocacy, and government relations strategies.
This unique program provides innovative and affordable opportunities to startups and early-stage emerging companies with a solid technology or scientific foundation. We help companies that have a quality management team in place and do not have other significant legal representation.
eMerge’s lawyers and technologists work together to deliver strategic end-to-end eDiscovery and data management solutions for litigation, investigations, due diligence, and compliance matters. We help clients discover the information necessary to resolve disputes, respond to investigations, conduct due diligence, and comply with legal requirements.
NEW YORK – Troutman Pepper client Cognition Therapeutics, Inc. (NASDAQ: CGTX), a clinical-stage biopharmaceutical company, recently launched an initial public offering with the expected gross proceeds of approximately $45.2 million. Read a company press release announcing the pricing of its upsized IPO.
Cognition Therapeutics is engaged in the discovery and development of innovative, small molecule therapeutics targeting age-related degenerative diseases and disorders of the central nervous system and retina. The company aims to develop disease-modifying treatments for patients with these disorders by targeting the σ-2 (sigma-2) receptor, a key regulator of cellular damage cellular damage response.
The Troutman Pepper team advising Cognition Therapeutics was led by Rachael M. Bushey, Joseph Walsh, and Raymond A. Miller, and included Pierre Queiroz de Oliveira, Alexander Yarbrough, Michael Brito-Stamm, Immanuel Kim, Benjamin Stowers, Allison Nicklin, Judith O’Grady, Noreen Hibbard Onimus, David Kaplan, Sheri Adler, and Kahn Wiedis.
Troutman Pepper regularly counsels pharmaceutical, biotech, medical device, diagnostics, and other life sciences clients on all types of corporate matters, including in major mergers and acquisitions. The multidisciplinary team applies deep industry know-how and market insight to provide holistic guidance throughout clients’ business cycles.
About Troutman Pepper
Troutman Pepper is a national law firm with more than 1,200 attorneys strategically located in 23 U.S. cities. The firm’s litigation, transactional, and regulatory practices advise a diverse client base, from start-ups to multinational enterprises. The firm provides sophisticated legal solutions to clients’ most pressing business challenges, with depth across industry sectors, including construction, energy, finance, health sciences, insurance, private equity, real estate, and technology, among others. Learn more at troutman.com.
This just in
Speaking Engagements
Fundamentals of Investment Adviser Regulation 2026
November 19, 2026 | 2:30 PM – 3:30 PM ET
PLI New York
1177 Avenue of the Americas, Entrance on 45th Street, New York, NY 10036
Speaking Engagements
2026 Advanced eDiscovery Institute
November 19 – 20, 2026
Capital Hilton
1001 16th Street NW, Washington, DC 20036
Sponsored Events
ACG Charlotte 13th Annual Deal Crawl Conference
November 18 – 19, 2026
JW Marriott Charlotte
600 S College Street, Charlotte, NC 28202
Speaking Engagements
Environmental Due Diligence in M&A Transactions: Identifying Risks, Mitigating CERCLA Liability, Maintaining BFPP Protection Webinar
November 17, 2026
Virtual
